Harrow, Inc. (HROW): EPS (Basic)
-$0.14
Year ended 2025-12-31
| Period ended | EPS (Basic) | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$0.14 | n/m | 2026-03-02, From 2025-01-01 |
| 2024-12-31 | -$0.49 | n/m | 2026-03-02, From 2024-01-01 |
| 2023-12-31 | -$0.75 | n/m | 2026-03-02, From 2023-01-01 |
| 2022-12-31 | -$0.51 | n/m | 2024-03-19, From 2022-01-01 |
| 2021-12-31 | -$0.69 | n/m | 2023-03-23, From 2021-01-01 |
| 2020-12-31 | -$0.13 | n/m | 2021-03-08, From 2020-01-01 |
| 2019-12-31 | $0.01 | -98.5% | 2021-03-08, From 2019-01-01 |
| 2018-12-31 | $0.67 | n/m | 2020-03-13, From 2018-01-01 |
| 2017-12-31 | -$0.60 | n/a | 2019-03-12, From 2017-01-01 |
EPS (Basic) at similar companies
| Company | Year ended | EPS (Basic) | Change YoY |
|---|---|---|---|
| Harrow, Inc. (HROW) | 2025-12-31 | -$0.14 | n/m |
| Vireo Growth Inc. (VREOF) | 2025-12-31 | -$0.09 | n/m |
| Ligand Pharmaceuticals Inc (LGND) | 2025-12-31 | $6.44 | n/m |
| Arvinas, Inc. (ARVN) | 2025-12-31 | -$1.14 | n/m |
| Schrodinger, Inc. (SDGR) | 2025-12-31 | -$1.41 | n/m |
| Xeris Biopharma Holdings, Inc. (XERS) | 2025-12-31 | $0.00 | n/m |
| Ironwood Pharmaceuticals Inc (IRWD) | 2025-12-31 | $0.15 | n/m |
| Evolus, Inc. (EOLS) | 2025-12-31 | -$0.80 | n/m |
| Arcus Biosciences, Inc. (RCUS) | 2025-12-31 | -$3.29 | n/m |
Compare HROW, VREOF, LGND, ARVN side by side · Screen every company in Pharmaceutical Preparations ↗